Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05358535 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)

Study acronym: PEAC
StatusRecruiting
PhasePhase 3
Started2022-09-19
View on ClinicalTrials.gov ↗

Amendment history

2026-01-16
Study Status, Contacts/Locations v11
Primary completion date2025-12→2027-01
Completion date2026-03→2027-03
Study sitescontacts updated at 1 of 1 site
2025-10-17
Study Status v10
Primary completion date2025-09→2025-12
Completion date2025-09→2026-03
2025-02-26
Study Status v9
Primary completion date2024-12→2025-09
Completion date2024-12→2025-09
2024-07-18
Study Identification, Study Status, Sponsor/Collaborators v8
Primary completion date2024-06→2024-12
2023-07-27
Study Status, Contacts/Locations v7
Primary completion date2023-12→2024-06
Completion date2024-06→2024-12
Show 6 earlier versions
2022-10-31
Study Status v6
Re-verified, no change to tracked fields
2022-09-15
Study Status v5
Start date2022-08→2022-09-19
2022-08-09
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations, IPDSharing v4
Trial statusNot Yet Recruiting→Recruiting
Study sites0→1
2022-07-26
Study Status, Arms and Interventions v3
Re-verified, no change to tracked fields
2022-07-21
Study Status, Study Design, Eligibility v2
Primary completion date2023-06→2023-12
Completion date2023-12→2024-06
Enrollment target150→200
Eligibility criteria+40 characters
[...] endoscopic procedure at CUH with anesthesia ASA 3 or above Ejection Fraction test result available Exclusion Criteria: Known allergies or adverse reactions to [...]
2022-07-18
Study Status v1
Start date2022-06→2022-08
2022-05-02
Original filing
The purpose of this study is to evaluate the hemodynamics and adverse event profile in comparison between two treatment arms, one using an admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7), and one using an admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2), for anesthesia during endoscopic procedures at the Clements University Hospital (CUH) endoscopy lab (Endo).
Trial Details
NCT Number NCT05358535
Lead Sponsor University of Texas Southwestern Medical Center
Conditions Anesthesia, Propofol Adverse Reaction, Etomidate Adverse Reaction, Anesthesia Complication, Anesthesia; Adverse Effect, Anesthesia; Reaction
Enrollment 200 participants
Start Date 2022-09-19
Primary Completion 2027-01 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-01-20